ArticleJournal of clinical medicine2026
GLP-1 Receptor Agonists or Dual GLP-1/GIP Receptor Agonists vs. SGLT2 Inhibitors in Patients with Atrial Fibrillation and HFpEF: A Propensity-Matched Real-World Analysis.
Faizan Ahmed et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.